Our focus is patients, 
Our passion is innovation®

MannKind Corporation develops patient-focused drug therapies and innovative technology solutions.

More

Advanced Science 
Practical Design

We specialize in innovative technologies with proven ease-of-use and patient acceptance.

More

Patient-Friendly
Inhalation Treatments

Needle-free, self-administered Inhalation Treatment Systems for both chronic and acute diseases.

More

In Partnership
Your Drug, Our Delivery.

Our Technosphere® technology can accommodate a wide variety of APIs required by specific drug therapies.

More

About Us

MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes.  More

 

 

 

 

facebook-c_130x50      twitter_130x50

 

 

 

Annual Meeting of Stockholders of MannKind Corporation

 

May 16, 2018

10 a.m. PT

 

30930 Russell Ranch Road, Suite 301

Westlake Village, CA 91362

 

alfreeza

FDA Approved

For information about AFREZZA®,
please visit www.AFREZZA.com.

WARNING:


If you are reporting an Adverse Event and/or device complaint, please contact MannKind Medical Information at 1-877-323-8505 or MannKind@druginfo.com. Do not use this form for adverse events and/or device complaints.

Close